376 results match your criteria Neuromodulation Surgery for Psychiatric Disorders

Randomized double-blind sham-controlled trial of thalamic versus GPi stimulation in patients with severe medically refractory Gilles de la Tourette syndrome.

Brain Stimul 2021 Apr 18;14(3):662-675. Epub 2021 Apr 18.

Department of Neurosurgery, Hannover Medical School, Germany.

Background: There are still no sufficient data regarding the use of deep brain stimulation (DBS) in Gilles de la Tourette syndrome (GTS) and no agreement on optimal target.

Objective: To compare efficacy and safety of bilateral DBS of thalamus (centromedian-ventro-oral internus, CM-Voi) versus posteroventral lateral globus pallidus internus (pvl GPi)) versus sham stimulation, and baseline in severe medically refractory GTS.

Methods: In this randomized double-blind sham stimulation-controlled trial (RCT), 10 patients (3 women, mean age = 29. Read More

View Article and Full-Text PDF

International Consensus Based Review and Recommendations for Minimum Reporting Standards in Research on Transcutaneous Vagus Nerve Stimulation (Version 2020).

Front Hum Neurosci 2020 23;14:568051. Epub 2021 Mar 23.

Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States.

Given its non-invasive nature, there is increasing interest in the use of transcutaneous vagus nerve stimulation (tVNS) across basic, translational and clinical research. Contemporaneously, tVNS can be achieved by stimulating either the auricular branch or the cervical bundle of the vagus nerve, referred to as transcutaneous auricular vagus nerve stimulation(VNS) and transcutaneous cervical VNS, respectively. In order to advance the field in a systematic manner, studies using these technologies need to adequately report sufficient methodological detail to enable comparison of results between studies, replication of studies, as well as enhancing study participant safety. Read More

View Article and Full-Text PDF

Advanced Imaging in Psychiatric Neurosurgery: Toward Personalized Treatment.

Neuromodulation 2021 Mar 31. Epub 2021 Mar 31.

Department of Neurological Surgery, Vanderbilt University Medical Center, Nashville, TN, USA.

Objectives: Our aim is to review several recent landmark studies discussing the application of advanced neuroimaging to guide target selection in deep brain stimulation (DBS) for psychiatric disorders.

Materials And Methods: We performed a PubMed literature search of articles related to psychiatric neurosurgery, DBS, diffusion tensor imaging, probabilistic tractography, functional magnetic resonance imaging (MRI), and blood oxygen level-dependent activation. Relevant articles were included in the review. Read More

View Article and Full-Text PDF

The 5 Pillars in Tourette Syndrome Deep Brain Stimulation Patient Selection: Present and Future.

Neurology 2021 04 16;96(14):664-676. Epub 2021 Feb 16.

From the Department of Clinical Neurosciences (D.M., T.M.P.), Cumming School of Medicine, University of Calgary, Calgary AB, Canada; Hotchkiss Brain Institute (D.M., T.M.P.), University of Calgary, Calgary AB, Canada; Alberta Children's Hospital Research Institute (D.M.), University of Calgary, Calgary AB, Canada; Mathison Centre for Mental Health Research and Education (D.M., T.M.P.), Calgary, AB, Canada; UMass Memorial Medical Center and UMass Medical School (W.D.), Worcester, MA, United States; Department of Neurology (J.J.-S.), Icahn School of Medicine at Mount Sinai, New York, NY, United States; Department of Neurology (I.M., M.S.O.), Norman Fixel Institute for Neurological Diseases, University of Florida Health, Gainesville, FL, United States; Department of Psychiatry (T.M.P.), Pediatrics and Community Health Sciences, University of Calgary, AB, Canada; Edmond J. Safra Program in Parkinson's Disease (A.F.), Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, UHN, Toronto, Ontario, Canada; Division of Neurology, University of Toronto, Toronto, Ontario, Canada; Krembil Brain Institute (A.F.), Toronto, Ontario, Canada; CenteR for Advancing Neurotechnological Innovation to Application (CRANIA) (A.F.), Toronto, ON, Canada; Movement Disorders and Neuromodulation Unit (C.G.), Charité, University Medicine Berlin, Department of Neurology, Berlin, Germany; and Strategic Regulatory Partners (W.W.), LLC.

The selection of patients with Tourette syndrome (TS) for deep brain stimulation (DBS) surgery rests on 5 fundamental pillars. However, the operationalization of the multidisciplinary screening process to evaluate these pillars remains highly diverse, especially across sites. High tic severity and tic-related impact on quality of life (first 2 pillars) require confirmation from objective, validated measures, but malignant features of TS should per se suffice to fulfill this pillar. Read More

View Article and Full-Text PDF

Training in the practice of noninvasive brain stimulation: Recommendations from an IFCN committee.

Clin Neurophysiol 2021 Mar 3;132(3):819-837. Epub 2020 Dec 3.

Hinda and Arthur Marcus Institute for Aging Research and Deanna and Sidney Wolk Center for Memory Health, Hebrew SeniorLife and Department of Neurology, Harvard Medical School, Boston, MA, USA; Guttmann Brain Health Institute, Institut Guttmann, Universitat Autonoma, Barcelona, Spain. Electronic address:

As the field of noninvasive brain stimulation (NIBS) expands, there is a growing need for comprehensive guidelines on training practitioners in the safe and effective administration of NIBS techniques in their various research and clinical applications. This article provides recommendations on the structure and content of this training. Three different types of practitioners are considered (Technicians, Clinicians, and Scientists), to attempt to cover the range of education and responsibilities of practitioners in NIBS from the laboratory to the clinic. Read More

View Article and Full-Text PDF

State-dependent responses to intracranial brain stimulation in a patient with depression.

Nat Med 2021 02 18;27(2):229-231. Epub 2021 Jan 18.

Department of Psychiatry, University of California, San Francisco, San Francisco, CA, USA.

Deep brain stimulation is a promising treatment for severe depression, but lack of efficacy in randomized trials raises questions regarding anatomical targeting. We implanted multi-site intracranial electrodes in a severely depressed patient and systematically assessed the acute response to focal electrical neuromodulation. We found an elaborate repertoire of distinctive emotional responses that were rapid in onset, reproducible, and context and state dependent. Read More

View Article and Full-Text PDF
February 2021

Deep Brain Stimulation for Alzheimer's Disease: Tackling Circuit Dysfunction.

Neuromodulation 2021 Feb 30;24(2):171-186. Epub 2020 Dec 30.

USC Neurorestoration Center, Keck School of Medicine of USC, Los Angeles, CA, 90033, USA.

Objectives: Treatments for Alzheimer's disease are urgently needed given its enormous human and economic costs and disappointing results of clinical trials targeting the primary amyloid and tau pathology. On the other hand, deep brain stimulation (DBS) has demonstrated success in other neurological and psychiatric disorders leading to great interest in DBS as a treatment for Alzheimer's disease.

Materials And Methods: We review the literature on 1) circuit dysfunction in Alzheimer's disease and 2) DBS for Alzheimer's disease. Read More

View Article and Full-Text PDF
February 2021

The Therapeutic Potential of Purinergic Receptors in Alzheimer's Disease and Promising Therapeutic Modulators.

Mini Rev Med Chem 2020 Dec 9. Epub 2020 Dec 9.

Department of Nuclear Medicine, Laboratory of Clinical Nuclear Medicine, West China Hospital, Sichuan University, Chengdu 610041, Sichuan,. China.

Recent studies have proven that the purinergic signaling pathway plays a key role in neurotransmission and neuromodulation, and is involved in various neurodegenerative diseases and psychiatric disorders. With the characterization of the subtypes of receptors in purinergic signaling, i.e. Read More

View Article and Full-Text PDF
December 2020

Probabilistic Mapping of Deep Brain Stimulation: Insights from 15 Years of Therapy.

Ann Neurol 2021 03 21;89(3):426-443. Epub 2020 Dec 21.

Division of Neurosurgery, Department of Surgery, University Health Network and University of Toronto, Toronto, Ontario, Canada.

Deep brain stimulation (DBS) depends on precise delivery of electrical current to target tissues. However, the specific brain structures responsible for best outcome are still debated. We applied probabilistic stimulation mapping to a retrospective, multidisorder DBS dataset assembled over 15 years at our institution (n = 482 patients; n = 303; n = 64; n = 39; n = 76) to identify the neuroanatomical substrates of optimal clinical response. Read More

View Article and Full-Text PDF

Examining cognitive change in magnetic resonance-guided focused ultrasound capsulotomy for psychiatric illness.

Transl Psychiatry 2020 11 11;10(1):397. Epub 2020 Nov 11.

Harquail Centre for Neuromodulation, Hurvitz Brain Sciences Program, Sunnybrook Research Institute, Toronto, ON, Canada.

Magnetic resonance-guided focused ultrasound (MRgFUS) anterior capsulotomy is a novel treatment option for patients with refractory obsessive compulsive disorder (OCD) or major depressive disorder (MDD). However, there is concern that lesional psychiatric surgery procedures may have adverse effects on cognition. In this study, we examined whether MRgFUS capsulotomy causes cognitive decline in patients with psychiatric illness. Read More

View Article and Full-Text PDF
November 2020

Physical Plasticity of the Brain and Deep Brain Stimulation Lead: Evolution in the First Post-operative Week.

Front Surg 2020 25;7:55. Epub 2020 Aug 25.

Department of Neurology, College of Medicine, University of South Alabama, Mobile, AL, United States.

Deep brain stimulation (DBS) is a therapy for movement disorders and psychiatric conditions. In the peri-operative period, brain shift occurs as the consequence of events related to the brain surgery which results in post-operative lead deformation. To quantify post-operative 3-dimensional DBS lead deformation after implantation. Read More

View Article and Full-Text PDF

Three-Tesla Magnetic Resonance Imaging of Patients With Deep Brain Stimulators: Results From a Phantom Study and a Pilot Study in Patients.

Neurosurgery 2021 01;88(2):349-355

Division of Neurosurgery, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.

Background: Deep brain stimulation (DBS) is a standard of care treatment for multiple neurologic disorders. Although 3-tesla (3T) magnetic resonance imaging (MRI) has become the gold-standard modality for structural and functional imaging, most centers refrain from 3T imaging in patients with DBS devices in place because of safety concerns. 3T MRI could be used not only for structural imaging, but also for functional MRI to study the effects of DBS on neurocircuitry and optimize programming. Read More

View Article and Full-Text PDF
January 2021

Beneficial nonmotor effects of subthalamic and pallidal neurostimulation in Parkinson's disease.

Brain Stimul 2020 Nov - Dec;13(6):1697-1705. Epub 2020 Oct 7.

University of Cologne, Faculty of Medicine and University Hospital Cologne, Department of Neurology, Cologne, Germany; Department of Neurology, University Hospital Giessen and Marburg, Campus Marburg, Germany.

Background: Subthalamic (STN) and pallidal (GPi) deep brain stimulation (DBS) improve quality of life, motor, and nonmotor symptoms (NMS) in advanced Parkinson's disease (PD). However, few studies have compared their nonmotor effects.

Objective: To compare nonmotor effects of STN-DBS and GPi-DBS. Read More

View Article and Full-Text PDF

Longitudinal Changes After Amygdala Surgery for Intractable Aggressive Behavior: Clinical, Imaging Genetics, and Deformation-Based Morphometry Study-A Case Series.

Neurosurgery 2021 01;88(2):E158-E169

Laboratory of Neuromodulation, Teaching and Research Institute, Hospital Sirio-Libanes, Sao Paulo, Brazil.

Background: Intractable aggressive behavior (iAB) is a devastating behavioral disorder that may affect psychiatric patients. These patients have reduced quality of life, are more challenging to treat as they impose a high caregiver burden and require specialized care. Neuromodulatory interventions targeting the amygdala, a key hub in the circuitry of aggressive behavior (AB), may provide symptom alleviation. Read More

View Article and Full-Text PDF
January 2021

CLoSES: A platform for closed-loop intracranial stimulation in humans.

Neuroimage 2020 12 1;223:117314. Epub 2020 Sep 1.

Department of Neurology, Massachusetts General Hospital, Boston, MA, USA.

Targeted interrogation of brain networks through invasive brain stimulation has become an increasingly important research tool as well as therapeutic modality. The majority of work with this emerging capability has been focused on open-loop approaches. Closed-loop techniques, however, could improve neuromodulatory therapies and research investigations by optimizing stimulation approaches using neurally informed, personalized targets. Read More

View Article and Full-Text PDF
December 2020

Magnetic Resonance-Guided Focused Ultrasound Capsulotomy for Treatment-Resistant Psychiatric Disorders.

Oper Neurosurg (Hagerstown) 2020 Jul 31. Epub 2020 Jul 31.

Division of Neurosurgery, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Canada.

Background: Psychiatric surgery is an important domain of functional neurosurgery and involves deep brain stimulation (DBS) or lesional procedures performed for treatment-resistant psychiatric illness. It has recently become possible to use magnetic-guided focused ultrasound (MRgFUS) to perform bilateral capsulotomy, a lesional technique commonly carried out with surgical radiofrequency ablation or stereotactic radiosurgery. MRgFUS offers several advantages, including improved safety and real-time imaging of the lesions. Read More

View Article and Full-Text PDF

Evidence-Based Guidelines and Secondary Meta-Analysis for the Use of Transcranial Direct Current Stimulation in Neurological and Psychiatric Disorders.

Int J Neuropsychopharmacol 2021 Apr;24(4):256-313

Service of Interdisciplinary Neuromodulation, Laboratory of Neurosciences (LIM-27), Department and Institute of Psychiatry & Department of Internal Medicine, Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil.

Background: Transcranial direct current stimulation has shown promising clinical results, leading to increased demand for an evidence-based review on its clinical effects.

Objective: We convened a team of transcranial direct current stimulation experts to conduct a systematic review of clinical trials with more than 1 session of stimulation testing: pain, Parkinson's disease motor function and cognition, stroke motor function and language, epilepsy, major depressive disorder, obsessive compulsive disorder, Tourette syndrome, schizophrenia, and drug addiction.

Methods: Experts were asked to conduct this systematic review according to the search methodology from PRISMA guidelines. Read More

View Article and Full-Text PDF

Structural connectivity predicts clinical outcomes of deep brain stimulation for Tourette syndrome.

Brain 2020 08;143(8):2607-2623

Scientific Computing and Imaging Institute, University of Utah, Salt Lake City, Utah, USA.

Deep brain stimulation may be an effective therapy for select cases of severe, treatment-refractory Tourette syndrome; however, patient responses are variable, and there are no reliable methods to predict clinical outcomes. The objectives of this retrospective study were to identify the stimulation-dependent structural networks associated with improvements in tics and comorbid obsessive-compulsive behaviour, compare the networks across surgical targets, and determine if connectivity could be used to predict clinical outcomes. Volumes of tissue activated for a large multisite cohort of patients (n = 66) implanted bilaterally in globus pallidus internus (n = 34) or centromedial thalamus (n = 32) were used to generate probabilistic tractography to form a normative structural connectome. Read More

View Article and Full-Text PDF

Patient With Posttraumatic Stress Disorder Successfully Treated With Deep Brain Stimulation of the Medial Prefrontal Cortex and Uncinate Fasciculus.

Biol Psychiatry 2020 12 6;88(11):e57-e59. Epub 2020 Jul 6.

Sunnybrook Research Institute, Ontario, Canada; Harquail Centre for Neuromodulation, Sunnybrook Health Sciences Centre, University of Toronto, Ontario, Canada; Division of Neurosurgery, Sunnybrook Health Sciences Centre, University of Toronto, Ontario, Canada.

View Article and Full-Text PDF
December 2020

Dataset of quantitative structured office measurements of movements in the extremities.

Data Brief 2020 Aug 18;31:105876. Epub 2020 Jun 18.

Section of High Resolution Brain Positron Emission Tomography Imaging, Division of Nuclear Medicine and Molecular Imaging, The Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, MD, United States.

A low-cost quantitative structured office measurement of movements in the extremities of people with Parkinson's disease [1,2] was performed on people with Parkinson's disease, multiple system atrophy, and age-matched healthy volunteers. Participants underwent twelve videotaped procedures rated by a trained examiner while connected to four accelerometers [1,2] generating a trace of the three location dimensions expressed as spreadsheets [3,4]. The signals of the five repetitive motion items [1,2] underwent processing to fast Fourier [5] and continuous wavelet transforms [6]. Read More

View Article and Full-Text PDF

A brief demonstration of frontostriatal connectivity in OCD patients with intracranial electrodes.

Neuroimage 2020 10 4;220:117138. Epub 2020 Jul 4.

University of Cologne, Faculty of Medicine and University Hospital Cologne, Department of Psychiatry and Psychotherapy, University Hospital Cologne, Cologne, Germany; Department of Psychiatry, Psychotherapy, and Psychosomatics, Johanniter Hospital Oberhausen, Oberhausen, Germany.

Closed-loop neuromodulation is presumed to be the logical evolution for improving the effectiveness of deep brain stimulation (DBS) treatment protocols (Widge et al., 2018). Identifying symptom-relevant biomarkers that provide meaningful feedback to stimulator devices is an important initial step in this direction. Read More

View Article and Full-Text PDF
October 2020

Neuroimaging and electrophysiology meet invasive neurostimulation for causal interrogations and modulations of brain states.

Neuroimage 2020 10 4;220:117144. Epub 2020 Jul 4.

Movement Disorders and Neurostimulation, Biomedical Statistics and Multimodal Signal Processing Unit, Department of Neurology, Focus Program Translational Neuroscience (FTN), Rhine Main Neuroscience Network (rmn2), University Medical Center of the Johannes Gutenberg University Mainz, Germany. Electronic address:

Deep brain stimulation (DBS) has developed over the last twenty years into a highly effective evidenced-based treatment option for neuropsychiatric disorders. Moreover, it has become a fascinating tool to provide illustrative insights into the functioning of brain networks. New anatomical and pathophysiological models of DBS action have accelerated our understanding of neurological and psychiatric disorders and brain functioning. Read More

View Article and Full-Text PDF
October 2020

A unified connectomic target for deep brain stimulation in obsessive-compulsive disorder.

Nat Commun 2020 07 3;11(1):3364. Epub 2020 Jul 3.

Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Movement Disorders and Neuromodulation Unit, Department for Neurology, Charitéplatz 1, 10117 Berlin, Germany.

Multiple surgical targets for treating obsessive-compulsive disorder with deep brain stimulation (DBS) have been proposed. However, different targets may modulate the same neural network responsible for clinical improvement. We analyzed data from four cohorts of patients (N = 50) that underwent DBS to the anterior limb of the internal capsule (ALIC), the nucleus accumbens or the subthalamic nucleus (STN). Read More

View Article and Full-Text PDF

[Innovative therapeutic approaches in psychiatry : neuromodulation. For whom, why and how ?]

Rev Med Liege 2020 May;75(5-6):426-431

Service de Neurochirurgie, CHU Liège, Belgique.

Recent technological advances have seen the resumption or the advent of new approaches in the field of psychiatry such as electroconvulsive therapy, repeated transcranial magnetic stimulation, transcranial direct current electrical stimulation or even deep brain stimulation. These new approaches offer a window into the understanding of the neurobiological mechanisms linked to mental illnesses. This review summarizes current knowledges in the field and the future directions for the treatment of depression or obsessive-compulsive disorder. Read More

View Article and Full-Text PDF

Risk Factors and Survival Analysis of Spinal Cord Stimulator Explantation.

Neuromodulation 2021 Jan 3;24(1):61-67. Epub 2020 Jun 3.

Department of Epidemiology, University of Iowa, Iowa City, IA, USA.

Objective: The treatment failure rate for spinal cord stimulators (SCS) remains unacceptably high, with reports of removal in up to 30% of patients. The purpose of this study is to perform survival and multivariate regression analyses of patients who have undergone SCS explantation in order to identify patient characteristics that may predict treatment failure.

Materials And Methods: We identified 253 patients who underwent SCS placement using current procedural terminology codes in a private health insurance data base spanning 2003-2016. Read More

View Article and Full-Text PDF
January 2021

Tract-based analysis of target engagement by subcallosal cingulate deep brain stimulation for treatment resistant depression.

Brain Stimul 2020 Jul - Aug;13(4):1094-1101. Epub 2020 Mar 19.

Department of Clinical Neuroscience, University of Calgary, AB, Canada; Mathison Centre for Mental Health Research and Education, University of Calgary, Calgary, AB, Canada; Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada. Electronic address:

Background: Deep brain stimulation (DBS) of subcallosal cingulate cortex (SCC) is a promising investigational therapy for treatment-resistant depression (TRD). However, outcomes vary, likely due to suboptimal DBS placement. Ideal placement is proposed to stimulate 4 SCC white matter bundles; however, no quantitative data have linked activation of these target tracts to response. Read More

View Article and Full-Text PDF
December 2020

Repetitive TMS for sleep disorders: are we ready?

Giuseppe Lanza

Sleep Med 2020 07 9;71:111-112. Epub 2020 Mar 9.

Department of Surgery and Medical-Surgical Specialties, University of Catania, Via Santa Sofia, 78, 95125, Catania, Italy; Department of Neurology IC, Oasi Research Institute - IRCCS, Via Conte Ruggero, 73, 94018, Troina, Italy. Electronic address:

View Article and Full-Text PDF

Sleep, Noninvasive Brain Stimulation, and the Aging Brain: Challenges and Opportunities.

Ageing Res Rev 2020 08 4;61:101067. Epub 2020 May 4.

Siena Brain Investigation and Neuromodulation Lab (Si-BIN Lab), Department of Medicine, Surgery and Neuroscience, Neurology and Clinical Neurophysiology Section, University of Siena, Italy; Berenson-Allen Center for Noninvasive Brain Stimulation, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. Electronic address:

As we age, sleep patterns undergo severe modifications of their micro and macrostructure, with an overall lighter and more fragmented sleep structure. In general, interventions targeting sleep represent an excellent opportunity not only to maintain life quality in the healthy aging population, but also to enhance cognitive performance and, when pathology arises, to potentially prevent/slow down conversion from e.g. Read More

View Article and Full-Text PDF

DBS: a compelling example for ethical and legal reflection-a French perspective on ethical and legal concerns about DBS.

Monash Bioeth Rev 2020 May;38(1):15-34

NormaStim Program ANR14-CE30-0016, University of Nantes (UMR 6297 DCS), Nantes, France.

Deep brain stimulation (DBS) is an approved treatment for neurological diseases and a promising one for psychiatric conditions, which may produce spectacular results very quickly. It is also a powerful tool for brain research and exploration. Beyond an overview of the ethical and legal literature on this topic, this paper aims at showing that DBS is a compelling example for ethical-legal reflection, as it combines a highly technical surgical procedure, a complex active medical device and neuromodulation of the human brain to restore lost abilities caused by a chronic and evolving disease. Read More

View Article and Full-Text PDF

Modulation of Human Memory by Deep Brain Stimulation of the Entorhinal-Hippocampal Circuitry.

Neuron 2020 04;106(2):218-235

Department of Neurosurgery, University of California, Los Angeles, Los Angeles, CA 90095, USA; Department of Psychiatry and Biobehavioral Sciences, University of California, Los Angeles, Los Angeles, CA 90095, USA; Tel Aviv Medical Center and Tel Aviv University, Tel Aviv, Israel. Electronic address:

Neurological disorders affecting human memory present a major scientific, medical, and societal challenge. Direct or indirect deep brain stimulation (DBS) of the entorhinal-hippocampal system, the brain's major memory hub, has been studied in people with epilepsy or Alzheimer's disease, intending to enhance memory performance or slow memory decline. Variability in the spatiotemporal parameters of stimulation employed to date notwithstanding, it is likely that future DBS for memory will employ closed-loop, nuanced approaches that are synergistic with native physiological processes. Read More

View Article and Full-Text PDF